Division of Pharmacognosy, Department of Pharmaceutical Sciences, University of Vienna, Vienna, Austria.
Vienna Doctoral School of Pharmaceutical, Nutritional, and Sport Sciences, University of Vienna, Vienna, Austria.
Planta Med. 2024 Jun;90(7-08):576-587. doi: 10.1055/a-2254-0131. Epub 2024 Jun 6.
The average age of the population is increasing worldwide, which has a profound impact on our society. This leads to an increasing demand for medicines and requires the development of new strategies to promote health during the additional years. In the search for resources and therapeutics for improved health during an extended life span, attention has to be paid to environmental exposure and ecosystem burdens that inevitably emerge with the extended consumption of medicines and drug development, even in the preclinical stage. The hereby introduced sustainable strategy for drug discovery is built on 3Rs, "R: obustness, R: eliability, and saving R: esources", inspired by both the 3Rs used in animal experiments and environmental protection, and centers on the usefulness and the variety of the small model organism for detecting health-promoting natural products. A workflow encompassing a multilevel screening approach is presented to maximize the amount of information on health-promoting samples, while considering the 3Rs. A detailed, methodology- and praxis-oriented compilation and discussion of proposed health span assays and more disease-specific assays are presented to offer guidance for scientists intending to work with , thus facilitating the initial steps towards the integration of assays in their laboratories.
全球人口的平均年龄正在增长,这对我们的社会产生了深远的影响。这导致对药物的需求不断增加,需要制定新的策略来促进额外年份的健康。在寻找资源和治疗方法以延长寿命期间,必须注意环境暴露和生态系统负担,这些负担不可避免地随着药物的延长使用和药物开发而出现,甚至在临床前阶段也是如此。本文介绍的药物发现可持续策略是基于 3R 构建的,即“R:稳健性、R:可靠性和节省 R:资源”,这既受到动物实验中使用的 3R 的启发,也受到环境保护的启发,其核心是利用小型模式生物的有用性和多样性来检测促进健康的天然产物。提出了一种包含多层次筛选方法的工作流程,以最大限度地提高有关促进健康样本的信息量,同时考虑到 3R。详细、方法和实践导向的建议健康跨度测定法和更具疾病特异性的测定法的汇编和讨论,为希望使用它们的科学家提供了指导,从而促进了将测定法整合到他们实验室的初始步骤。